key: cord-0923056-wx514vnm authors: Cannata, Antonio; Bromage, Daniel I.; Rind, Irfan A.; Gregorio, Caterina; Bannister, Clare; Albarjas, Mohammed; Piper, Susan; Shah, Ajay M.; McDonagh, Theresa A. title: Temporal trends in decompensated heart failure and outcomes during COVID‐19: A multisite report from heart failure referral centres in London. date: 2020-08-18 journal: Eur J Heart Fail DOI: 10.1002/ejhf.1986 sha: c1ef6e55d3c9523bac014a8bb07c9f6a0493c29a doc_id: 923056 cord_uid: wx514vnm AIMS: Admission rates for acute decompensated heart failure declined during COVID‐19. However, the impact of this reduction on hospital mortality is unknown. We describe temporal trends in the presentation of patients with acute heart failure (HF) and their in‐hospital outcomes from two referral centres in London during the COVID‐19 pandemic. METHODS AND RESULTS: A total of 1372 patients hospitalized for HF in two referral centres in South London between 7(th) January and 14(th) June 2020, were included in the study and compared to the same time period in 2019. The primary outcome was all‐cause in‐hospital mortality. HF hospitalizations were significantly reduced during the COVID‐19 pandemic, compared to 2019 (p<0.001). Specifically, we observed a temporary reduction in hospitalizations during the COVID‐19 peak, followed by a return to 2019 levels. Patients admitted during the COVID‐19 pandemic had similar demographic characteristics compared to the same period in 2019. However, in‐hospital mortality was significantly higher in 2020 compared to 2019 (p=0.015). Hospitalization in 2020 was independently associated with worse in‐hospital mortality (hazard ratio [HR] 2.23, 95% Confidence Interval [CI] 1.34 – 3.72; p=0.002). CONCLUSION: During the COVID‐19 pandemic there was a reduction in HF hospitalizations and higher in‐hospital mortality. Hospitalisation for HF in 2020 is independently associated with more adverse outcomes. Further studies are required to investigate the predictors of these adverse outcomes to help inform potential changes to the management of HF patients while some constraints to usual care remain. This article is protected by copyright. All rights reserved. The COVID-19 pandemic has been the most difficult public health emergency of our time and has dramatically affected all healthcare systems, requiring reconfiguration of usual care. The UK, and especially London, experienced the highest burden of COVID-19 in Europe (1) . Multiple measures were been adopted to limit the spread of the virus. Together with these measures, healthcare was reconfigured. This resulted in a reduction in speciality bed availability and the redeployment of specialist cardiology staff. Those staff remaining in Cardiology looked after a broader range of cardiac conditions than prior to the pandemic. Over the last months, a persistent decline in admission for many cardiovascular conditions has been observed (2) (3) (4) (5) (6) . As with acute coronary syndromes, hospitalization for heart failure (HF) declined progressively during the COVID-19 pandemic and patients presenting to hospital had a more advanced phenotype compared to similar periods in previous years (4) . So far, data on heart failure hospitalization after the peak of pandemic, potentially surging to normal or above normal levels, are scant. As reported by the National Heart Failure Audit in the UK, between 5% to 10% of patients hospitalized with HF die in-hospital and more than 30% of those discharged after an acute decompensation experience an adverse outcome within 12 months of the index hospitalization (7) . Whether the reduction in hospital admissions for HF during COVID-19 is associated with more adverse outcomes is still unknown. The aim of the present study is to describe temporal trends of hospitalization with HF throughout the pandemic and, importantly, the associated in-hospital outcomes. This was a prospective cohort study of unselected patients hospitalized for HF. Consecutive patients, older than 18 years, with HF presenting to two referral centres in London, King's College Hospital and Princess Royal University Hospital, from 7 th January to 14 th June 2020 were included in the study and compared to the same time period in 2019. To exclude possible extrinsic factors influencing HF admissions, the first week of January was excluded from the analysis, and observation was started from the 7th of January. The "COVID-19 time" has been defined as from the first COVID-19 death in the UK, the 2nd of March, until the last day of lockdown when commerce reopened in England, the 14th of June. Patients were included in the analysis if they had a discharge diagnosis of HF in the first or second diagnostic position according to appropriate ICD codes (I11.0 Hypertensive heart disease with (congestive) heart failure; I25.5 Ischaemic cardiomyopathy; I42.0 Dilated cardiomyopathy; I42.9 Cardiomyopathy, unspecified; I50.0 Congestive heart failure; I50.1 Left ventricular failure; I50.9 Heart failure, unspecified). This information was extracted from our local Hospital Episode Statistics (HES) data. The primary outcomes of the study were trends in hospitalization for HF throughout the observation time period and in-hospital mortality. Ethnicity, speciality ward allocation at admission and discharge, length of stay and readmission rates were also available for analysis. A pre-defined subgroup analysis, to evaluate the impact of COVID-19, considered only the time frame from 2 nd March to 14 th of June 2020. Variables are expressed as mean and standard deviation, median and interquartile range, or counts and percentage, as appropriate. The results are reported following "Strengthening the Reporting of Observational Studies in Epidemiology" (STROBE) guidelines (2) . Baseline characteristics were compared using the Pearson Chi square test for categorical variables or the Student's t-test for continuous variables, using the Brown-Forsythe statistic when the assumption of equal variances did not hold, or by the non-parametric Mann-Whitney U test when necessary. Normality of This article is protected by copyright. All rights reserved. Accepted Article distribution was assessed using the Shapiro-Wilks test. To fit hospitalization trends in both cohorts a cubic term and a quadratic term were used and compared by means of the extra-sum-of-square F test. Survival curves for in-hospital mortality were estimated and compared between years by means of the log-rank test. To adjust for possible confounders in estimating the association between year of admission and prognosis of HF admission, a multivariable Cox regression models were estimated from an unselected list of candidate prognostic variables obtained from the univariable analyses (i.e. those with a p-value <=0.1). The IBM-SPSS statistical software version 25.0 (IBM Corp., NY, USA), and the software R (R Foundation for Statistical Computing, Vienna, Austria. URL https://www.r-project.org/) were used for statistical analyses. A sensitivity analysis, including only in patients with HF in either the first or second diagnostic position, was conducted to ascertain the potential differences in mortality according to diagnostic position. Furthermore, a sensitivity analysis excluding patients with concurrent COVID-19 infection and HF has been performed. During the study period, a total of 1372 hospitalizations for HF were included. Of those, 794 occurred from 7 th January to 14 th of June 2019 and 578 in the same period in 2020. Trends of HF admission were different in 2019 compared to 2020 (p<0.001). While hospitalizations for HF were consistent over the study period in 2019, hospitalizations progressively declined during the COVID-19 pandemic followed by a gradual return to baseline until the end of the study period in June 2020 ( Figure 1 ). Similar trends were observed when considering HF in either the first or second diagnostic position (Supplementary Figure 1 ). This article is protected by copyright. All rights reserved. Patients admitted during the whole study period had similar demographic characteristics ( Table 1) . However, in 2020 more patients were admitted to general medicine wards compared to 2019 (83% vs. 77%, respectively; p=0.008). Length of stay was comparable between 2019 and 2020 (6 days, interquartile range [IQR] 3;12 vs. 7 days IQR 3;14, respectively; p=0.29) with the latter showing a lower readmission rate (5% in 2020 vs. 8% in 2019, p=0.03). Similarly, in the pre-specified subgroup analysis, demographic characteristics of patients with HF during COVID-19 were comparable whereas length of in-hospital stay was one day shorter during COVID-19 compared to the same period in 2019 (6 days, IQR 3;11 in 2020 vs. 7 days IQR 2;13 in 2019, p=0.03) ( Table 2 ). Patients admitted with HF in 2020 experienced worse outcomes compared to 2019. Indeed, inhospital mortality was significantly higher in 2020 compared to 2019 (Figure 2 -left In the pre-defined subgroup analysis, among patients admitted from 2 nd March to 14 th of June 2020 (the COVID pandemic), cumulative survival in 2020 was significantly lower compared to 2019 (Figure 2 -right panel, p=0.001) . Conversely, in-hospital outcomes were comparable in the population admitted from January to March (p=0.55). Sensitivity analyses confirmed that, when considering only patients admitted with HF in the first diagnostic position, patients hospitalized in 2020 experienced more adverse outcomes compared to those hospitalized in 2019 (Supplementary figure 2, p=0.019) . Conversely, for patients admitted with HF in second diagnostic position, differences in mortality were less pronounced (Supplementary figure 3, p=0.49) . Lastly, only 9 patients had confirmed COVID-19. The finding This article is protected by copyright. All rights reserved. Accepted Article of worse mortality among HF patients admitted during the COVID-19 pandemic was confirmed in a sensitivity analysis excluding patients with concurrent coronavirus infection (data not shown). The impact of the COVID-19 pandemic on healthcare systems has been all encompassing. Similar to other cardiovascular conditions (3, 7) , hospital admissions for decompensated HF have consistently declined during the outbreak (2, 4) . So far, all available reports have focussed on either admission for various cardiovascular conditions during the peak of the pandemic or COVID-19related mortality in patients with underlying heart disease (2, 6, (8) (9) (10) . Although excess out-ofhospital mortality has been reported and attributed mainly to a higher incidence of pulmonary embolism (11) , an increase in HF-related mortality has not been described to date. In the present analysis, we build on our previous findings regarding trends in HF hospitalization (2), highlighting the resurgence of admissions following the peak of the pandemic and reporting an excess of HFrelated in-hospital mortality. We recently reported that, despite reduced hospitalization rates during COVID-19, patients were more unwell compared to previous years (2) . This might be partially explained by the potential fear of infection from COVID-19 resulting in avoidance of hospital presentation unless absolutely necessary. Our present report highlights that the significant drop of hospitalizations for HF has been followed by a rebound in HF admissions after the peak of the pandemic, returning to pre-pandemic levels just before the release of lockdown measures (Figure 1) . It extends our previously reported findings by incorporating a bigger cohort, recruited on two sites and with an extended capture of HF patients, using HES data and not just National HF Audit submissions (the National HF Audit only requires 70% of HES-coded HF admissions in the first diagnostic position to be submitted). There were similar trends for both HF coded in the first and second diagnostic positions (Supplementary Figure 1) . Whether this will be followed by a surge of HF hospitalization remains to be seen. This article is protected by copyright. All rights reserved. In our analysis, together with the significant reduction in HF hospitalizations, we observed a difference in the place of management of HF patients. Despite demographic characteristics being similar during COVID-19 compared to 2019, a higher percentage of patients were managed in general medical wards, partially attributable to the reduced cardiology bed-availability and to redeployment of Cardiology specialists towards other areas. The changes in place of care were also paralleled by a slightly shorter length of hospitalization during COVID-19 (6 days, IQR 3;11 in 2020 vs. 7 days IQR 2;13 in 2019, p=0.03) but it is not known if these are causally related. Whether redeployment of HF specialists and redesign of pathways of outpatient care have contributed to changes in patients' management remain unknown and require future research. In other countries, virtual management of HF patients still allowed direct access to specialist care (12) . Similarly, in our service, close telemonitoring of stable HF patients and the continuation of dedicated face-toface clinic appointments for those with new incident HF and for patients with more advanced HF might have partially prevented exacerbation of their clinical condition. It has been widely reported that patients hospitalized for COVID-19 with concomitant cardiac disease have a worse prognosis than those without a history of cardiac disease (9) . However, inhospital mortality of patients admitted primarily with HF during the pandemic has not been reported yet. A recent study from Denmark (10) described a rebound in HF hospitalizations after lockdown ended, but did not observe any difference in mortality, which might relate to the relatively low impact of COVID-19 in Denmark. Our analysis is the first to address the relationship between COVID-19 and in-hospital mortality in a large population of patients with acute decompensated HF. Patients hospitalized for HF during the first six months of 2020 had significantly worse outcomes compared to the same period in 2019 (Figure 2A) . Subgroup analysis suggested that this was driven by a higher incidence of in-hospital This article is protected by copyright. All rights reserved. Accepted Article mortality during the COVID-19 pandemic ( Figure 2B) . Conversely, being admitted in the first two months of 2020 was not associated with increased in-hospital mortality. Multivariable analysis revealed that together with older age, being admitted in 2020 was independently associated with more adverse outcomes both in the total population and in those admitted during the COVID-19 pandemic (Graphical abstract, HR 2.23, p=0.002). There are several potential reasons for this. On one hand, as recently reported, patients hospitalized with HF during the pandemic were sicker, including a higher NYHA class and worse congestion, compared to those hospitalized in the same period in 2019 (2) . Indeed, the previously described more advanced HF status at admission during COVID-19 might result in higher inhospital mortality in this population. On the other hand, although direct cardiac involvement of SARS-CoV-2 has not been demonstrated so far, concomitant asymptomatic and undiagnosed COVID-19 infection cannot be excluded but seems unlikely given the number of tests performed on inpatients during the COVID-19 pandemic. To date, this is the first report showing increased inhospital mortality for patients admitted primarily for HF during the COVID-19 pandemic. Larger analyses are required to investigate the epidemiology and the mortality of HF patients over this troublesome year to detect whether changes of care may have played a role in this setting. This study has been conducted in two HF referral centres in South London. Therefore, the results might not be generalizable to other places with different COVID-19 incidence and require further confirmation in widespread multicentre analysis. The present analysis has been conducted on all of the admissions. Clinical characteristics, such as NYHA class, classification of HF and the degree of congestion, were not available for this analysis for all patients. Limiting the analysis to patients with available clinical data or presenting variables with a high percentage of missing values might have introduced selection bias and, thereby, confounded the results. The lower readmission rate in 2020 This article is protected by copyright. All rights reserved. Accepted Article might be partially explained by the relatively short post-discharge observational period. Further research is advocated to identify the predictors of the increased mortality during COVID-19. The COVID-19 pandemic has placed an enormous burden on healthcare systems globally. The reduction in HF hospitalizations during the pandemic is paralleled by a higher in-hospital mortality and being admitted for HF in 2020 is independently associated with more adverse outcomes. Further studies are required to investigate the predictors of that higher mortality and to confirm these results in other countries. This article is protected by copyright. All rights reserved. Table 1 . Demographic characteristics of the total population from January to the 14 th of June. European Centre for Disease Prevention and Control. COVID-19 situation update for the EU/EEA and the UK The impact of COVID-19 on heart failure hospitalization and management: report from a Heart Failure Unit in London during the peak of the pandemic Admission of patients with STEMI since the outbreak of the COVID-19 pandemic. A survey by the European Society of Cardiology Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy Declines in Hospitalizations for Acute This article is protected by copyright Accepted Article Cardiovascular Conditions During the COVID-19 Pandemic: A Multicenter Tertiary Care Experience Reductions in Heart Failure Hospitalizations During the COVID-19 Pandemic The STROBE initiative: STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy Incidence of New-Onset and Worsening Heart Failure Before and After the COVID-19 Epidemic Lockdown in Denmark: A Nationwide Cohort Study. Circ Heart Fail Excess out-of-hospital deaths during the COVID-19 outbreak: evidence of pulmonary embolism as a main determinant Heart failure management during the COVID-19 outbreak in Italy: a telemedicine experience from a heart failure university tertiary referral centre Accepted Article We are grateful to the staff of the King's College Hospital and the Princess Royal University Hospital who helped in the fight against COVID-19, and to all the staff who supported data collection. This article is protected by copyright. All rights reserved.Accepted Article This article is protected by copyright. All rights reserved.Accepted Article